Gujarat Themis Biosyn Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 4,51,552 shares,. Its Average Traded Price (ATP) is ₹425.02, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹425.85.
Gujarat Themis Biosyn has an upper circuit limit of ₹507.15 and a lower circuit limit of ₹338.15. The total value traded stands at ₹19.19 CR, and the delivery percentage for the day is 59.79%.
The stock is currently traded with a market lot size of 1. Gujarat Themis Biosyn also offers a dividend yield of 0.16%.
Gujarat Themis Biosyn Share Price Chart
Gujarat Themis Biosyn Share Key Metrics
Volume
4.52 L
Market Cap
4605.42 CR
LTQ@LTP
2@425.85
ATP
425.02
Var Margin
24.96 %
Circuit Range
338.15-507.15
Delivery %
59.79 %
Value
19.19 CR
ASM/GSM
No
Market Lot
1
Gujarat Themis Biosyn Resistance and Support
Pivot 422.08
Resistance
First Resistance
430.56
Second Resistance
438.48
Third Resistance
446.96
Support
First Support
414.16
Second Support
405.68
Third Support
397.76
Gujarat Themis Biosyn Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Gujarat Themis Biosyn Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-10 | Others |
| 2026-09-01 | Preferential issue of shares |
| 2026-08-07 | Quarterly Results |
| 2026-06-19 | To consider Fund Raising |
| 2026-06-06 | Fund Raising & Others |
| 2026-05-25 | Audited Results |
| 2026-02-05 | Quarterly Results |
| 2025-11-10 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2025-09-04 | 2025-09-05 | View More |
| Bonus Date | Record Date | |
|---|---|---|
| 2024-05-14 | 2024-08-09 | View More |
Gujarat Themis Biosyn News
Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 10.09.2026
Gujarat Themis Biosyn's board approved issuance of Non-Convertible Debentures (NCDs) up to ₹585 crores via private placement. This move aims to strengthen the company's capital structure, with further disclosures to be made at the time of allotment.
Sep 10 2026 19:37:01
Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Intimation for Raising Funds Through Issue Of Non-Convertible Debentures By Way Of Private Placement.
Gujarat Themis Biosyn's Board of Directors is scheduled to meet on September 10, 2026. The key agenda for this meeting is to approve raising funds through the issuance of Non-Convertible Debentures by way of private placement.
Sep 07 2026 20:03:05
Gujarat Themis Biosyn Ltd - 506879 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Gujarat Themis Biosyn's promoter group experienced a passive reduction in shareholding percentage by 11.53%, bringing their total stake to 59.33%. This change is a result of the allotment of 2.11 crore equity shares to non-promoters through a Qualified Institutional Placement on August 28, 2026.
Sep 02 2026 11:35:50
Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 01-09-2026
Gujarat Themis Biosyn's board approved a preferential issue of 82.10 lakh equity shares at ₹408 per share, aggregating ₹335.00 crore. The issue will involve both promoter and non-promoter groups.
Sep 01 2026 17:00:29
Gujarat Themis Biosyn Ltd - 506879 - Announcement under Regulation 30 (LODR)-Allotment
Gujarat Themis Biosyn announced the allotment of 2.11 crore equity shares to Qualified Institutional Buyers (QIBs) at an issue price of Rs. 354 per share, including a premium of Rs. 353. The company successfully raised Rs. 750 crore through this Qualified Institutions Placement (QIP).
Aug 28 2026 22:58:30
Gujarat Themis Biosyn Ltd - 506879 - Announcement under Regulation 30 (LODR)-Qualified Institutional Placement
Gujarat Themis Biosyn has closed its Qualified Institutional Placement (QIP) issue period on August 28, 2026. The company will allot 2.11 crore equity shares at Rs. 354 each, raising approximately Rs. 750 crore, at a 4.98% discount to the floor price of Rs. 372.57.
Aug 28 2026 20:41:55
Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Intimation for Intimation Of The Board Meeting
Gujarat Themis Biosyn's Board of Directors will meet on September 1, 2026. The key agenda is to consider and approve a proposal to raise funds through a preferential issue of equity shares and/or convertible warrants on a private placement basis.
Aug 27 2026 18:39:56
Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Outcome for Outcome Of Board Meeting Related To QIP
Gujarat Themis Biosyn Board approved a Qualified Institutional Placement (QIP) of equity shares to Qualified Institutional Buyers (QIBs). The floor price for the QIP has been fixed at ₹372.57 per share, with a potential discount of up to 5%.
Aug 25 2026 23:29:28
Gujarat Themis Biosyn Ltd - 506879 - Announcement Under Reg 30 (LODR) - Updates (Audited Financial Statements)
Gujarat Themis Biosyn disclosed two significant acquisitions post FY26: an asset purchase agreement for anti-TB and anti-infective brands from Sanofi for EUR 158 million, and 100% equity in MicroBiopharm Japan for JPY 21.5 billion. These deals, totaling over Rs.2,700 crore, aim to strengthen the company's product portfolio and market presence, with completion expected by Dec 2026 and Q2 FY27 respectively.
Aug 25 2026 21:34:30
Gujarat Themis Biosyn Ltd - 506879 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Gujarat Themis Biosyn shareholders approved an amendment to the Articles of Association through a Postal Ballot. This change removes the requirement for a valuation report when shares are transferred for cash or other consideration.
Aug 23 2026 15:47:48
Gujarat Themis Biosyn Management
| Name | Position |
|---|---|
| Vineet G Gawankar | Company Secretary & Compliance Officer |
| Dinesh S Patel | Chairman |
Gujarat Themis Biosyn Similar Stocks
Innova Captab Ltd.
1142.10
-5.10 (0.44%)
Morepen Laboratories Ltd.
106.94
-8.84 (7.64%)
Orchid Pharma Ltd.
989.75
-13.30 (1.33%)
IOL Chemicals And Pharmaceuticals Ltd.
180.60
-13.71 (7.06%)
FDC Ltd.
352.70
11.25 (3.29%)
Artemis Medicare Services Ltd.
331.75
-13.15 (3.81%)
Supriya Lifescience Ltd.
879.65
-22.10 (2.45%)
RPG Life Sciences Ltd.
2754.60
56.00 (2.08%)
SMS Pharmaceuticals Ltd.
408.85
-54.60 (11.78%)
Gufic Biosciences Ltd.
426.00
0.90 (0.21%)
Gujarat Themis Biosyn FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GUJTHEM
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC